The UCLA trial is currently enrolling patients.
Levee Medical®, a medical device company focused on improving outcomes for prostate cancer surgery patients, today announced continued progress in the clinical and commercial advancement of its Voro® ...
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U ...
News-Medical.Net on MSN
PSA-based tool improves decision making for prostate cancer screening and treatment
Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate ...
HUNTSVILLE, Ala. (WAFF) - On Tuesday, July 8, the Urology Health Foundation will hold a free prostate cancer screening for men 40 years of age and older from 10:00 a.m. until 4:00 p.m. at the Madison ...
Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...
Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...
Former President Joe Biden has been diagnosed with an "aggressive" form of prostate cancer that has spread to his bones. But what does it mean for this type of cancer to be called aggressive? As a ...
A new face will be leading Northwell’s urology department. Dr. Samir S. Taneja has been appointed senior vice president and system chair of urology at Northwell and chair of the Smith Institute for ...
Prostate MRI currently lacks the accuracy to replace biopsies in active surveillance for prostate cancer. The negative predictive value of MRI remains below 90%, the general goal for safely avoiding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback